Intervacc is trading 15.75% down at β¬0.06, with no reliable explanation identified for the October 1, 2026 movement.
- The latest identified company update, on September 15, announced CEO Carl-Johan Dalsgaardβs participation in the Swiss Nordic Bio Conference on October 1; it does not establish a cause for the drop.
- The broader market information provided shows no significant same-direction move that would explain it.